|
Market Closed -
London S.E.
16:35:27 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1150 GBX | 0.00% |
|
-1.71% | -46.51% |
| Market Cap | 5.75M 6.68M 5.41M 4.94M 9.24M 631M 9.27M 63.9M 24.8M 324M 25.08M 24.53M 1.04B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 10.65M 12.38M 10.02M 9.15M 17.12M 1.17B 17.17M 118M 45.95M 600M 46.48M 45.46M 1.93B | EV / Sales 2026 * |
5.69x | EV / Sales 2027 * | - |
| Free-Float |
92.83% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| OBD | Delayed | |
OTC Markets
| OXBOF | Delayed | |
|
Börse Stuttgart
| LMQ | Delayed | |
|
Deutsche Boerse AG
| LMQ | Delayed |
| 1 week | -1.71% | ||
| Current month | -4.17% | ||
| 1 month | +4.55% | ||
| 3 months | -28.57% | ||
| 6 months | -54.00% | ||
| Current year | -46.51% |
| 1 week | 0.11 |  | 0.13 |
| 1 month | 0.1 | | 0.15 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 53.6 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Compton
CEO | Chief Executive Officer | - | 29/06/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 07/06/2007 | |
Paul Stockdale
DFI | Director of Finance/CFO | - | 14/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 07/06/2007 | |
Paul Stockdale
BRD | Director/Board Member | - | 14/09/2017 |
David Holbrook
BRD | Director/Board Member | 65 | 04/04/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/11/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.71% | -74.44% | -98.96% | 6.68M | |
| -2.13% | +7.86% | +21.89% | -81.34% | 2.43B | |
| +3.03% | -40.26% | -51.09% | -59.77% | 1.46B | |
| -0.21% | +0.84% | -14.00% | -6.45% | 357M | |
| -0.22% | +1.79% | -46.35% | - | 53.83M | |
| Average | +0.07% | -7.87% | -32.80% | -61.63% | 861.05M | |
| Weighted average by Cap. | -0.26% | -11.05% | -6.83% | -67.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87M 2.18M 1.76M 1.61M 3.01M 205M 3.02M 20.81M 8.08M 105M 8.17M 7.99M 339M | - |
| Net income | - | - |
| Net Debt | 4.9M 5.7M 4.61M 4.21M 7.88M 538M 7.9M 54.51M 21.15M 276M 21.4M 20.93M 889M | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | GBX 0.1150 | 0.00% | 12,551,409 |
| 03/09/26 | GBX 0.1150 | -4.17% | 213,635,888 |
| 02/09/26 | GBX 0.1200 | 0.00% | 7,181,324 |
| 01/09/26 | GBX 0.1200 | 0.00% | 2,665,486 |
| 28/08/26 | GBX 0.1200 | +2.56% | 21,540,567 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001150GBP
Average target price
0.0100GBP
Spread / Average Target
+769.57%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Select your edition
All financial news and data tailored to specific country editions
